Downhill Walking Training in COPD
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02113748|
Recruitment Status : Unknown
Verified April 2014 by Thierry Troosters, KU Leuven.
Recruitment status was: Recruiting
First Posted : April 15, 2014
Last Update Posted : April 15, 2014
This randomized control trial will investigate whether a modality that generates more contractile muscle fatigue with lower ventilatory requirements render better results after a 12-week exercise training program in subjects with COPD.
Subjects will be randomized to either exercise in a training program including downhill walking or to exercise in a training program including conventional walking.
|Condition or disease||Intervention/treatment||Phase|
|Pulmonary Disease, Chronic Obstructive||Other: Downhill walking training Other: Conventional walking training||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||42 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Downhill Walking to Enhance Training Effects in Patients With COPD|
|Study Start Date :||April 2014|
|Estimated Primary Completion Date :||April 2015|
Experimental: Downhill walking training
Exercise training including treadmill walking with a negative inclination.
Other: Downhill walking training
Walk on a treadmill with a negative inclination.
Active Comparator: Conventional walking training
Exercise training including treadmill walking without inclination. Possible to progress training intensity with positive inclinations.
Other: Conventional walking training
Walk on a treadmill without inclination. Possible to progress training intensity with positive inclinations
- changes in 6-minute walking distance [ Time Frame: changes from baseline to Week 12 ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02113748
|Contact: Thierry Troosters, PhD||Thierry.Troosters@kuleuven.be|
|University Hospitals Leuven||Recruiting|
|Leuven, Vl-Brabant, Belgium, 3000|
|Contact: Thierry Troosters, PhD Thierry.Troosters@kuleuven.be|
|Sub-Investigator: Carlos Augusto Camillo, MSc|
|Principal Investigator: Thierry Troosters, PhD|
|Principal Investigator: Wim Janssens, MD, PhD|
|Principal Investigator:||Thierry Troosters, PhD||KU Leuven|